Literature DB >> 34315827

Structural basis of mismatch recognition by a SARS-CoV-2 proofreading enzyme.

Chang Liu1, Wei Shi2, Scott T Becker3, David G Schatz1, Bin Liu2, Yang Yang3.   

Abstract

Coronavirus 3′-to-5′ exoribonuclease (ExoN), residing in the nonstructural protein (nsp) 10–nsp14 complex, boosts replication fidelity by proofreading RNA synthesis and is critical for the virus life cycle. ExoN also recognizes and excises nucleotide analog inhibitors incorporated into the nascent RNA, undermining the effectiveness of nucleotide analog–based antivirals. Here we present cryo–electron microscopy structures of both wild-type and mutant severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nsp10-nsp14 in complex with an RNA substrate bearing a 3′-end mismatch at resolutions ranging from 2.5 to 3.9 angstroms. The structures reveal the molecular determinants of ExoN substrate specificity and offer insight into the molecular mechanisms of mismatch correction during coronavirus RNA synthesis. Our findings provide guidance for rational design of improved anticoronavirus therapies.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34315827     DOI: 10.1126/science.abi9310

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  33 in total

1.  Characterization of the SARS-CoV-2 ExoN (nsp14ExoN-nsp10) complex: implications for its role in viral genome stability and inhibitor identification.

Authors:  Hannah T Baddock; Sanja Brolih; Yuliana Yosaatmadja; Malitha Ratnaweera; Marcin Bielinski; Lonnie P Swift; Abimael Cruz-Migoni; Haitian Fan; Jeremy R Keown; Alexander P Walker; Garrett M Morris; Jonathan M Grimes; Ervin Fodor; Christopher J Schofield; Opher Gileadi; Peter J McHugh
Journal:  Nucleic Acids Res       Date:  2022-02-22       Impact factor: 16.971

2.  SARS-CoV-2 virus NSP14 Impairs NRF2/HMOX1 activation by targeting Sirtuin 1.

Authors:  Shilei Zhang; Jingfeng Wang; Lulan Wang; Saba Aliyari; Genhong Cheng
Journal:  Cell Mol Immunol       Date:  2022-06-23       Impact factor: 22.096

Review 3.  The Potential of Purinergic Signaling to Thwart Viruses Including SARS-CoV-2.

Authors:  Davide Ferrari; Michele Rubini; Jorge S Burns
Journal:  Front Immunol       Date:  2022-06-17       Impact factor: 8.786

4.  Inhibition of SARS-CoV-2 polymerase by nucleotide analogs from a single-molecule perspective.

Authors:  Mona Seifert; Subhas C Bera; Pauline van Nies; Robert N Kirchdoerfer; Ashleigh Shannon; Thi-Tuyet-Nhung Le; Xiangzhi Meng; Hongjie Xia; James M Wood; Lawrence D Harris; Flavia S Papini; Jamie J Arnold; Steven Almo; Tyler L Grove; Pei-Yong Shi; Yan Xiang; Bruno Canard; Martin Depken; Craig E Cameron; David Dulin
Journal:  Elife       Date:  2021-10-07       Impact factor: 8.713

Review 5.  Conquer by cryo-EM without physically dividing.

Authors:  Gabriel C Lander; Robert M Glaeser
Journal:  Biochem Soc Trans       Date:  2021-11-01       Impact factor: 4.919

6.  Search and sequence analysis tools services from EMBL-EBI in 2022.

Authors:  Fábio Madeira; Matt Pearce; Adrian R N Tivey; Prasad Basutkar; Joon Lee; Ossama Edbali; Nandana Madhusoodanan; Anton Kolesnikov; Rodrigo Lopez
Journal:  Nucleic Acids Res       Date:  2022-04-12       Impact factor: 19.160

Review 7.  Structural biology of SARS-CoV-2: open the door for novel therapies.

Authors:  Weizhu Yan; Yanhui Zheng; Xiaotao Zeng; Bin He; Wei Cheng
Journal:  Signal Transduct Target Ther       Date:  2022-01-27

8.  SIRT5 is a proviral factor that interacts with SARS-CoV-2 Nsp14 protein.

Authors:  Marius Walter; Irene P Chen; Albert Vallejo-Gracia; Ik-Jung Kim; Olga Bielska; Victor L Lam; Jennifer M Hayashi; Andrew Cruz; Samah Shah; John D Gross; Nevan J Krogan; Birgit Schilling; Melanie Ott; Eric Verdin
Journal:  bioRxiv       Date:  2022-01-05

9.  Coronaviral RNA-methyltransferases: function, structure and inhibition.

Authors:  Radim Nencka; Jan Silhan; Martin Klima; Tomas Otava; Hugo Kocek; Petra Krafcikova; Evzen Boura
Journal:  Nucleic Acids Res       Date:  2022-01-25       Impact factor: 16.971

Review 10.  Medicinal chemistry strategies towards the development of effective SARS-CoV-2 inhibitors.

Authors:  Shenghua Gao; Tianguang Huang; Letian Song; Shujing Xu; Yusen Cheng; Srinivasulu Cherukupalli; Dongwei Kang; Tong Zhao; Lin Sun; Jian Zhang; Peng Zhan; Xinyong Liu
Journal:  Acta Pharm Sin B       Date:  2021-08-31       Impact factor: 11.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.